Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Targeting intracellular signaling as an antiviral strategy: aerosolized LASAG for the treatment of influenza in hospitalized patients.

Scheuch G, Canisius S, Nocker K, Hofmann T, Naumann R, Pleschka S, Ludwig S, Welte T, Planz O.

Emerg Microbes Infect. 2018 Mar 7;7(1):21. doi: 10.1038/s41426-018-0023-3.

2.

Pharmacodynamics, Pharmacokinetics, and Antiviral Activity of BAY 81-8781, a Novel NF-κB Inhibiting Anti-influenza Drug.

Droebner K, Haasbach E, Dudek SE, Scheuch G, Nocker K, Canisius S, Ehrhardt C, von Degenfeld G, Ludwig S, Planz O.

Front Microbiol. 2017 Nov 2;8:2130. doi: 10.3389/fmicb.2017.02130. eCollection 2017.

3.

Delivery of Alpha-1 Antitrypsin to Airways.

Griese M, Scheuch G.

Ann Am Thorac Soc. 2016 Aug;13 Suppl 4:S346-51. doi: 10.1513/AnnalsATS.201507-469KV. Review.

PMID:
27564672
4.

Patient Focus and Regulatory Considerations for Inhalation Device Design: Report from the 2015 IPAC-RS/ISAM Workshop.

Roche N, Scheuch G, Pritchard JN, Nopitsch-Mai C, Lakhani DA, Saluja B, Jamieson J, Dundon A, Wallace R, Holmes S, Cipolla D, Dolovich MB, Shah SA, Lyapustina S.

J Aerosol Med Pulm Drug Deliv. 2017 Feb;30(1):1-13. doi: 10.1089/jamp.2016.1326. Epub 2016 Aug 18.

PMID:
27537608
5.

Nebulised budesonide using a novel device in patients with oral steroid-dependent asthma.

Vogelmeier C, Kardos P, Hofmann T, Canisius S, Scheuch G, Muellinger B, Nocker K, Menz G, Rabe KF.

Eur Respir J. 2015 May;45(5):1273-82. doi: 10.1183/09031936.00152014. Epub 2014 Dec 10.

6.

Aerosolized GLP-1 for treatment of diabetes mellitus and irritable bowel syndrome.

Siekmeier R, Hofmann T, Scheuch G, Pokorski M.

Adv Exp Med Biol. 2015;849:23-38. doi: 10.1007/5584_2014_94. Review.

PMID:
25427821
7.

Inhalation of macrolides: a novel approach to treatment of pulmonary infections.

Siekmeier R, Hofmann T, Scheuch G.

Adv Exp Med Biol. 2015;839:13-24. doi: 10.1007/5584_2014_50. Review.

PMID:
25252902
8.

Bioequivalence of inhaled drugs: fundamentals, challenges and perspectives.

Apiou-Sbirlea G, Newman S, Fleming J, Siekmeier R, Ehrmann S, Scheuch G, Hochhaus G, Hickey A.

Ther Deliv. 2013 Mar;4(3):343-67. doi: 10.4155/tde.12.161. Review.

PMID:
23442081
9.

Inhaler competence in asthma: common errors, barriers to use and recommended solutions.

Inhaler Error Steering Committee, Price D, Bosnic-Anticevich S, Briggs A, Chrystyn H, Rand C, Scheuch G, Bousquet J.

Respir Med. 2013 Jan;107(1):37-46. doi: 10.1016/j.rmed.2012.09.017. Epub 2012 Oct 23. Review.

10.

Effects of formoterol and tiotropium bromide on mucus clearance in patients with COPD.

Meyer T, Reitmeir P, Brand P, Herpich C, Sommerer K, Schulze A, Scheuch G, Newman S.

Respir Med. 2011 Jun;105(6):900-6. doi: 10.1016/j.rmed.2011.02.007. Epub 2011 Mar 11.

11.

Deposition, imaging, and clearance: what remains to be done?

Scheuch G, Bennett W, Borgström L, Clark A, Dalby R, Dolovich M, Fleming J, Gehr P, Gonda I, O'Callaghan C, Taylor G, Newman S.

J Aerosol Med Pulm Drug Deliv. 2010 Dec;23 Suppl 2:S39-57. doi: 10.1089/jamp.2010.0839. Review.

PMID:
21133799
12.

Mucociliary and cough clearance as a biomarker for therapeutic development.

Bennett WD, Daviskas E, Hasani A, Mortensen J, Fleming J, Scheuch G.

J Aerosol Med Pulm Drug Deliv. 2010 Oct;23(5):261-72. doi: 10.1089/jamp.2010.0823. Review.

PMID:
20804426
13.
14.

Treatment of systemic diseases by inhalation of biomolecule aerosols.

Siekmeier R, Scheuch G.

J Physiol Pharmacol. 2009 Nov;60 Suppl 5:15-26. Review.

PMID:
20134033
15.

Safety and tolerability of inhaled heparin in idiopathic pulmonary fibrosis.

Markart P, Nass R, Ruppert C, Hundack L, Wygrecka M, Korfei M, Boedeker RH, Staehler G, Kroll H, Scheuch G, Seeger W, Guenther A.

J Aerosol Med Pulm Drug Deliv. 2010 Jun;23(3):161-72. doi: 10.1089/jamp.2009.0780.

PMID:
20109123
16.

Left-to-right asymmetry of aerosol deposition after shallow bolus inhalation depends on lung ventilation.

Möller W, Meyer G, Scheuch G, Kreyling WG, Bennett WD.

J Aerosol Med Pulm Drug Deliv. 2009 Dec;22(4):333-9. doi: 10.1089/jamp.2009.0749.

PMID:
19580369
17.

Inhaled insulin--does it become reality?

Siekmeier R, Scheuch G.

J Physiol Pharmacol. 2008 Dec;59 Suppl 6:81-113. Review.

PMID:
19218634
18.

Systemic treatment by inhalation of macromolecules--principles, problems, and examples.

Siekmeier R, Scheuch G.

J Physiol Pharmacol. 2008 Dec;59 Suppl 6:53-79. Review.

PMID:
19218633
19.

Particle clearance from the airways of subjects with bronchial hyperresponsiveness and with chronic obstructive pulmonary disease.

Scheuch G, Kohlhäufl M, Möller W, Brand P, Meyer T, Häussinger K, Sommerer K, Heyder J.

Exp Lung Res. 2008 Nov;34(9):531-49. doi: 10.1080/01902140802341710.

PMID:
19005919
20.

[Perspectives in the inhalative administration of drugs].

Haidl P, Scheuch G.

Pneumologie. 2008 Jun;62(6):330-6. doi: 10.1055/s-2008-1038128. Review. German.

PMID:
18535977
21.

Aerosol science, medicine, the Journal, and ISAM in the 21st century.

Diot P, Scheuch G, Laube B, Smaldone G.

J Aerosol Med Pulm Drug Deliv. 2008 Jun;21(2):157-8. doi: 10.1089/jamp.2008.ED02. No abstract available.

PMID:
18518791
22.

Novel approaches to enhance pulmonary delivery of proteins and peptides.

Scheuch G, Siekmeier R.

J Physiol Pharmacol. 2007 Nov;58 Suppl 5(Pt 2):615-25. Review.

23.

Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.

Scheuch G, Brand P, Meyer T, Herpich C, Müllinger B, Brom J, Weidinger G, Kohlhäufl M, Häussinger K, Spannagl M, Schramm W, Siekmeier R.

J Physiol Pharmacol. 2007 Nov;58 Suppl 5(Pt 2):603-14.

24.

Inhalation of tobramycin in patients with cystic fibrosis: comparison of two methods.

Dopfer R, Brand P, Müllinger B, Hunger T, Häussermann S, Meyer T, Scheuch G, Siekmeier R.

J Physiol Pharmacol. 2007 Nov;58 Suppl 5(Pt 1):141-54.

25.

Inhaled insulin: take a deep breath, but how?

Heinemann L, Scheuch G, Heise T.

J Diabetes Sci Technol. 2008 Mar;2(2):297-9.

26.

Deposition, retention, and translocation of ultrafine particles from the central airways and lung periphery.

Möller W, Felten K, Sommerer K, Scheuch G, Meyer G, Meyer P, Häussinger K, Kreyling WG.

Am J Respir Crit Care Med. 2008 Feb 15;177(4):426-32. Epub 2007 Oct 11.

PMID:
17932382
27.

Lung deposition of radiolabeled tiotropium in healthy subjects and patients with chronic obstructive pulmonary disease.

Brand P, Meyer T, Weuthen T, Timmer W, Berkel E, Wallenstein G, Scheuch G.

J Clin Pharmacol. 2007 Oct;47(10):1335-41. Epub 2007 Jul 11.

PMID:
17625157
28.

Clinical perspectives on pulmonary systemic and macromolecular delivery.

Scheuch G, Kohlhaeufl MJ, Brand P, Siekmeier R.

Adv Drug Deliv Rev. 2006 Oct 31;58(9-10):996-1008. Epub 2006 Aug 12. Review.

PMID:
16996638
29.

[Comparison of unspecific bronchial provocation during controlled and spontaneous inhalation].

Wenzel C, Brand P, Herpich C, Häussermann S, Meyer T, Müllinger B, Scheuch G, Häussinger K.

Pneumologie. 2006 Aug;60(8):467-71. German.

PMID:
16933188
30.

The physical and biological doses of methacholine are different for Mefar MB3 and Jaeger APS sidestream nebulizers.

Praml G, Scharrer E, de la Motte D, Nowak D, Scheuch G, Sommerer K, Radon K.

Chest. 2005 Nov;128(5):3585-9.

PMID:
16304317
31.

[Effects of particulate air pollution on human health. Statement of the German Society of Pneumology on the discussion about fine particulate air pollution].

Voshaar TH, Heyder J, Köhler D, Krug N, Nowak D, Scheuch G, Schulz H, Witt C.

Pneumologie. 2005 Jul;59(7):470-6. German. No abstract available.

PMID:
16047281
32.

Optimum peripheral drug deposition in patients with cystic fibrosis.

Brand P, Meyer T, Häussermann S, Schulte M, Scheuch G, Bernhard T, Sommerauer B, Weber N, Griese M.

J Aerosol Med. 2005 Spring;18(1):45-54.

PMID:
15741773
33.

Inhaling to mitigate exhaled bioaerosols.

Edwards DA, Man JC, Brand P, Katstra JP, Sommerer K, Stone HA, Nardell E, Scheuch G.

Proc Natl Acad Sci U S A. 2004 Dec 14;101(50):17383-8. Epub 2004 Dec 6.

34.

[Inhaled antibiotic therapy in bronchiectasis?].

Kohlhäufl M, Scheuch G, Häussinger K.

Pneumologie. 2004 Jul;58(7):499-504. Review. German.

PMID:
15257472
35.

Deposition of Foradil P in human lungs: comparison of in vitro and in vivo data.

Meyer T, Brand P, Ehlich H, Köbrich R, Meyer G, Riedinger F, Sommerer K, Weuthen T, Scheuch G.

J Aerosol Med. 2004 Spring;17(1):43-9.

PMID:
15120012
36.

Improvement of alveolar glutathione and lung function but not oxidative state in cystic fibrosis.

Griese M, Ramakers J, Krasselt A, Starosta V, Van Koningsbruggen S, Fischer R, Ratjen F, Müllinger B, Huber RM, Maier K, Rietschel E, Scheuch G.

Am J Respir Crit Care Med. 2004 Apr 1;169(7):822-8. Epub 2004 Jan 15.

PMID:
14726422
37.

Pulmonary deposition of monodisperse aerosols in patients with chronic obstructive pulmonary disease.

Meyer T, Müllinger B, Sommerer K, Scheuch G, Brand P, Beckmann H, Häussinger K, Weber N, Siekmeier R.

Exp Lung Res. 2003 Oct-Nov;29(7):475-84.

PMID:
14710439
38.

[Controlled inhalation of beta2-sympaticomimetica after bronchial provocation].

Meyer T, Brand P, Herpich C, Scheuch G, Weber N.

Pneumologie. 2003 Nov;57(11):644-7. German.

PMID:
14618507
39.

Peripheral deposition of alpha1-protease inhibitor using commercial inhalation devices.

Brand P, Beckmann H, Maas Enriquez M, Meyer T, Müllinger B, Sommerer K, Weber N, Weuthen T, Scheuch G.

Eur Respir J. 2003 Aug;22(2):263-7.

40.

Can aerosol-derived airway morphometry detect early, asymptomatical lung emphysema?

Brand P, Letzel S, Buchta M, Scheuch G, Windorfer K, Hilla W, Smith HJ, Kraus T.

J Aerosol Med. 2003 Summer;16(2):143-51.

PMID:
12823908
41.

The inhalation manager: a new computer-based device to assess inhalation technique and drug delivery to the patient.

Kamin WE, Genz T, Roeder S, Scheuch G, Cloes R, Juenemann R, Trammer T.

J Aerosol Med. 2003 Spring;16(1):21-9.

PMID:
12737681
42.

[Difficulties in controlled inhalation of alpha 1-protease inhibitor].

Brand P, Maas Enriquez M, Meyer T, Scheuch G, Weber N.

Pneumologie. 2003 Mar;57(3):153-8. Review. German.

PMID:
12632295
43.

In vitro testing of two formoterol dry powder inhalers at different flow rates.

Weuthen T, Roeder S, Brand P, Müllinger B, Scheuch G.

J Aerosol Med. 2002 Fall;15(3):297-303.

PMID:
12396417
44.

In vitro and in vivo dose delivery characteristics of large porous particles for inhalation.

Dunbar C, Scheuch G, Sommerer K, DeLong M, Verma A, Batycky R.

Int J Pharm. 2002 Oct 1;245(1-2):179-89.

PMID:
12270254
45.

Targeting delivery of aerosols to different lung regions.

Bennett WD, Brown JS, Zeman KL, Hu SC, Scheuch G, Sommerer K.

J Aerosol Med. 2002 Summer;15(2):179-88. Review.

PMID:
12184868
46.

Mass output and particle size distribution of glucocorticosteroids emitted from different inhalation devices depending on various inspiratory parameters.

Kamin WE, Genz T, Roeder S, Scheuch G, Trammer T, Juenemann R, Cloes RM.

J Aerosol Med. 2002 Spring;15(1):65-73.

PMID:
12006147
47.

Inhalation of aerosolized vitamin a: reversibility of metaplasia and dysplasia of human respiratory epithelia -- a prospective pilot study.

Kohlhäufl M, Häussinger K, Stanzel F, Markus A, Tritschler J, Mühlhöfer A, Morresi-Hauf A, Golly I, Scheuch G, Jany BH, Biesalski HK.

Eur J Med Res. 2002 Feb 21;7(2):72-8.

PMID:
11891147
48.

Alveolar deposition of monodisperse aerosol particles in the lung of patients with chronic obstructive pulmonary disease.

Brand P, Meyer T, Sommerer K, Weber N, Scheuch G.

Exp Lung Res. 2002 Jan-Feb;28(1):39-54.

PMID:
11792074
49.

[Biophysical basics of aerosol therapy in bronchial asthma].

Scheuch G, Meyer T.

Z Arztl Fortbild Qualitatssich. 2001 Nov;95(10):693-7. German.

PMID:
11778321
50.

[Recommendations for the choice of inhalatory systems for drug prescription].

Voshaar T, App EM, Berdel D, Buhl R, Fischer J, Gessler T, Haidl P, Heyder J, Köhler D, Kohlhäufl M, Lehr CM, Lindemann H, Matthys H, Meyer T, Olschewski H, Paul KD, Rabe K, Raschke F, Scheuch G, Schmehl T, Schultze-Werninghaus G, Ukena D, Worth H; Arbeitsgruppe Aerosolmedizin der Deutschen Gesellschaft für Pneumologie.

Pneumologie. 2001 Dec;55(12):579-86. German. No abstract available.

PMID:
11748508

Supplemental Content

Loading ...
Support Center